When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Abiomed's AAA financials, including a clean balance sheet and world-class margins can justify a premium in its valuation.
Discounting Abiomed's future free cash flows, we derive the stock's intrinsic value, which comes to around ~$340/share, which is quite close to Abiomed's current stock price.
We remain cautiously bullish on Abiomed. While not a screaming Buy, the stock's valuation has not outrun the company's potential.